Search results
Results from the WOW.Com Content Network
Injection site reaction. Injection site reactions (ISRs) are reactions that occur at the site of injection of a drug. They may be mild or severe and may or may not require medical intervention. Some reactions may appear immediately after injection, and some may be delayed. [1] Such reactions can occur with subcutaneous, intramuscular, or ...
The most common side effects for ofatumumab (Kesimpta) include upper respiratory tract infection, headache, injection-related reactions, and local injection site reactions. [9] The most common side effects for ofatumumab (Arzerra) include infusion reactions and neutropenia. [14]
Injection site reactions such as redness and pain are common, occurring in approximately 11.4% of cases. [20] Dupilumab can cause allergic reactions, conjunctivitis, and keratitis and, due to its immunosuppressive effects, reactivation of cold sores. [7] In clinical trials, people receiving dupilumab had decreased levels of T helper cells. [21]
It depends on which monkeypox vaccine you get. In general, the CDC says that the following can be side effects of the JYNNEOS vaccine: The following may be side effects of the ACAM2000 vaccine ...
After Vitamin K injection is administered there are two potential cutaneous effects that can occur. The first is a local reaction of itchiness, eczema-like texture, indurated erythema on the skin at the injection site. The second is a generalized reaction that can show up as a skin lesion resembling a cyst.
An injection site reaction on the upper left arm. Side effects may include a lump at the injection site (injection site reaction) in approximately 30% of users, and aches, fever, chills (flu-like symptoms) in approximately 10% of users. [12] Side effect symptoms are generally mild in nature.
Degarelix is commonly associated with hormonal side effects such as hot flashes and weight gain. [7] [8] [9] Due to its mode of administration (subcutaneous injection), degarelix is also associated with injection-site reactions such as injection-site pain, erythema or swelling.
Injection site reactions are common, occurring in approximately 1.9% of cases. [9] In clinical trials there were rare instances of hypersensitivity reactions, severe infections, and some cases of serious inflammatory bowel disease, some of which were new and some of which were exacerbations of existing conditions. [5]